Why one backer of MDMA therapy sees ‘exponential’ growth following FDA approval this year

A financial backer of the effort to legalize the drug MDMA for therapeutic use sees the potential for “exponential growth” should it win approval from the U.S. Food and Drug Administration, possibly over this summer.

Previous post Chip stocks dive again, with SOX falling for a 4th straight session after closing at a record high
Next post Why ‘Dry January’ is a bad idea